Back to GOLDMAN SACHS GROUP INC GOLDMAN SACHS GROUP INC

BIIBBIIB
7 quarters

Position history for GOLDMAN SACHS GROUP INCGOLDMAN SACHS GROUP INC's holdings in BIOGEN INC

GOLDMAN SACHS GROUP INC holds 1.2M shares of BIIB (BIOGEN INC), worth $265.8M as of 2026-Q2. The position was increased (+17.1% shares). BIIB represents 0.0% of GOLDMAN SACHS GROUP INC's portfolio.

Current Value

$265.8M

Current Shares

1.2M

Total Value Change

+$148M

Total Shares Change

+460,070

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
1.2M
+17.1%
$265.8M0.0%$216.06
36
2026-Q1
Decreased
1.1M
-4.4%
$192.7M0.0%$183.33
0
2025-Q4
Increased
1.1M
+3.4%
$193.5M0.0%$175.99
32
2025-Q3
Increased
1.1M
+58.5%
$149M0.0%$140.08
43
2025-Q2
Increased
670,852
+10.9%
$84.3M0.0%$125.59
33
2025-Q1
Decreased
604,697
-21.5%
$82.7M0.0%$136.84
0
2024-Q4
New
770,320
-
$117.8M0.0%$152.92
42

Other major holders of BIIB: BNP PARIBAS FINANCIAL MARKETS, PRIMECAP MANAGEMENT CO/CA/

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used